A New Startup Wants to Use Crispr to Diagnose Disease
A New Startup Wants to Use Crispr to Diagnose Disease
Science, Spoken · SpokenLayer
April 27, 20188m 45s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In 2011, biologists Jennifer Doudna and Emmanuelle Charpentier published a landmark paper introducing the world to Crispr. The arcane family of bacterial proteins had a talent for precisely snipping DNA, and one of them—Cas9—has since inspired a billion-dollar boom in biotech investment. Clinical trials using Cas9 clippers to fix genetic defects are just beginning, so it will be years before Crispr-based cures could potentially reach the world.
Learn about your ad choices: dovetail.prx.org/ad-choices